# Bone Marrow-Derived Autologous Stem Cells for the Treatment of Duchenne Muscular Dystrophy

> **NCT03067831** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Stem Cells Arabia** · enrollment: 20 (estimated)

## Conditions studied

- Duchenne Muscular Dystrophy

## Interventions

- **BIOLOGICAL:** Stem Cells

## Key facts

- **NCT ID:** NCT03067831
- **Lead sponsor:** Stem Cells Arabia
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-09
- **Primary completion:** 2021-11
- **Final completion:** 2021-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2020-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03067831

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03067831, "Bone Marrow-Derived Autologous Stem Cells for the Treatment of Duchenne Muscular Dystrophy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03067831. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*